Being able to grow rudimentary brain tissue in the lab means that researchers can study organ development and disease. But how do you go from stem cells to a ‘mini-brain’? New LMB group leader Madelaine Lancaster’s research is highlighted in a report by the Long+Short magazine’s Ben Martynoga on the latest MRC Insight blog. More…
LMB In The News
Reviewing translation at the MRC
Work by LMB’s Mike Gait, Jason Chin and Satpal Virdee, and Fabrice Gorrec highlighted in a MRC Review of recent successes in translational research. More…
Cambridge Neuroscience 2015 Seminar at the LMB: Brain Chat podcast
Brain Chat – a podcast answering key questions about brain and behaviour, with Hannah Critchlow reporting on exciting brain research revolutions presented at the Cambridge Neuroscience 2015 Seminar held at LMB. More…
LMB contribution towards UK bioscience success illuminated
The stories behind three great LMB successes are highlighted in a report by the UK BioIndustry Association (BIA). Humira, the first fully humanised antibody and one of the worlds top selling drugs (pages 3-4), Lemtrada (CAMPATH) treatment for Multiple Sclerosis (pages 5-6) and the Stabilised GPCR StaR® technology which enables determination of receptor structures (pages […]
Cambridge scientists unlock cause of some types of infertility
LMB’s Melina Schuh, in collaboration with Bourn Hall Clinic, may have found the cause of some types of infertility, including recurrent miscarriage, after new research found some human eggs carry the wrong number of chromosomes. This article is no longer available from the source website: Cambridge News 19 June 2015
Sarah Teichmann receives EMBO Gold Award
The LMB congratulates former LMB Group Leader, Sarah Teichmann, on receiving the 2015 EMBO Gold Award. More…